Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria

UB-221 - United BioPharma

Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria (clinicaltrials.gov) - Nov 25, 2019 - P1; N=48; Not yet recruiting; Sponsor: United BioPharma
Clinical • New P1 trial

http://clinicaltrials.gov/ct2/show/NCT04175704

Nov 25, 2019